Hyperfine, Inc. (HYPR)

Data as of Aug 25, 2026, from SEC Form 4 filings.

Net insider selling (90d)Watch HYPR

See up to 3 months of HYPR. The 7-day demo opens the 1M and 3M ranges and puts HYPR on your watchlist.

Latest HYPR insider trades

Thomas Teisseyre - Officer
Open-market sale$6K
Aug 24, 2026
Brett Hale - Officer
Open-market sale$6K
Aug 24, 2026

About Hyperfine, Inc. (HYPR)

Hyperfine, Inc. files with the SEC under CIK 0001833769 and is classified as electromedical and electrotherapeutic apparatus. We track it alongside the rest of the Health Care sector.

Sector: Health Care

SEC filings for HYPR on EDGAR

HYPR Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Open-market sale	2	14,690	$13K

HYPR insider transactions (Form 4)

19 Form 4 filings on record, the earliest from Nov 18, 2024, newest first.

Date	Insider	Transaction	Security	Shares	Price	Value
Aug 24, 2026	Thomas Teisseyre - Officer	Open-market sale	Class A Common Stock	7,345^{footnote F1}	$0.85^{footnote F2}	$6K
Footnote F1 (shares): The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 31, 2025 pursuant to a "sell to cover" provision included in the RSU Agreement. Footnote F2 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $0.854 to $0.868 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR
Aug 24, 2026	Brett Hale - Officer	Open-market sale	Class A Common Stock	7,345^{footnote F1}	$0.85^{footnote F2}	$6K
Footnote F1 (shares): The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 31, 2025 pursuant to a "sell to cover" provision included in the RSU agreement. Footnote F2 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $0.854 to $0.868 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR
Jun 3, 2026	Dan Wolterman	Grant or award	Stock Options (right to buy)	52,600	$0.00	-
May 26, 2026	Brett Hale - Officer	Open-market sale	Class A Common Stock	6,047^{footnote F1}	$1.65^{footnote F2}	$10K
Footnote F1 (shares): The sales reported in ths Form 4 were effected to cover tax witholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 31, 2025 pursuant to a "sell to over" provision included in the RSU agreement. Footnote F2 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $1.63 to $1.715 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission… Full note on SEC EDGAR
May 26, 2026	Thomas Teisseyre - Officer	Open-market sale	Class A Common Stock	6,047^{footnote F1}	$1.65^{footnote F2}	$10K
Footnote F1 (shares): The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 31, 2025 pursuant to a "sell to cover" provision included in the RSU Agreement. Footnote F2 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $1.63 to $1.715 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission… Full note on SEC EDGAR
May 22, 2026	Ruth A. Fattori	Grant or award	Stock Options (right to buy)	157,700	$0.00	-
May 22, 2026	Dan Wolterman	Grant or award	Stock Options (right to buy)	157,700	$0.00	-
May 22, 2026	John T. Dahldorf	Grant or award	Stock Options (right to buy)	157,700	$0.00	-
May 22, 2026	Jonathan M. Rothberg	Grant or award	Stock Options (right to buy)	157,700	$0.00	-
Mar 31, 2026	Brett Hale - Officer	Grant or award	Class A Common Stock	330,000^{footnote F1}	$0.00	-
Footnote F1 (shares): Consist of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest 25% on March 23, 2027, with the remainder vesting in equal quarterly installments over the following three years, subject to Mr… Full note on SEC EDGAR
Mar 31, 2026	Thomas Teisseyre - Officer	Grant or award	Class A Common Stock	330,000^{footnote F1}	$0.00	-
Footnote F1 (shares): Consist of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest 25% on March 23, 2027, with the remainder vesting in equal quarterly installments over the following three years, subject to Dr… Full note on SEC EDGAR
Mar 31, 2026	Maria Sainz - Officer	Grant or award	Class A Common Stock	750,000^{footnote F1}	$0.00	-
Footnote F1 (shares): Consist of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest 25% on March 23, 2027, with the remainder vesting in equal quarterly installments over the following three years, subject to Ms… Full note on SEC EDGAR
Mar 23, 2026	Thomas Teisseyre - Officer	Open-market sale	Class A Common Stock	24,188	$1.21^{footnote F1}	$29K
Footnote F1 (price): The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 31, 2025 pursuant to a "sell to cover" provision included in the RSU Agreement.
Mar 23, 2026	Brett Hale - Officer	Open-market sale	Class A Common Stock	24,188^{footnote F1}	$1.21	$29K
Footnote F1 (shares): The sales reported in ths Form 4 were effected to cover tax witholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 31, 2025 pursuant to a "sell to over" provision included in the RSU agreement.
Feb 13, 2026	Thomas Teisseyre - Officer	Open-market sale	Class A Common Stock	821	$1.11^{footnote F1}	$913
Footnote F1 (price): The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 28, 2022 and April 28, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.
Nov 19, 2025	Thomas Teisseyre - Officer	Open-market sale	Class A Common Stock	1,405	$1.08^{footnote F1}	$2K
Footnote F1 (price): The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 28, 2022 and April 28, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.
Aug 18, 2025	Thomas Teisseyre - Officer	Open-market sale	Class A Common Stock	1,151	$1.33	$2K
May 20, 2025	Ruth A. Fattori	Grant or award	Stock Options (right to buy)	79,200	$0.00	-
Nov 18, 2024	Thomas Teisseyre - Officer	Open-market sale	Class A Common Stock	2,800	$0.85	$2K

Recent HYPR Form 8-K filings

Read HYPR company news

Oct 8, 2026Item 2.02, 7.01, 9.01

Read the filing on SEC EDGAR

Sep 18, 2026Item 3.01

Read the filing on SEC EDGAR

Aug 6, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

May 21, 2026Item 5.07

Read the filing on SEC EDGAR

HYPR insider trading FAQ

What is the latest insider trade for HYPR?

Hyperfine, Inc. (HYPR) had 2 insider filings in the last 90 days, with the most recent on 2026-08-25. The full record for HYPR runs to 19 Form 4 filings, the earliest from 2024-11-18. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying HYPR stock?

No insider purchases of HYPR were filed in the last 90 days.

How many insiders are selling HYPR stock?

2 insider sales of HYPR were filed in the last 90 days, totaling $13K.

Where can I see HYPR SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects HYPR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Aug 25, 2026 - Thomas Teisseyre view on EDGAR
Aug 25, 2026 - Brett Hale view on EDGAR
Jun 4, 2026 - Dan Wolterman view on EDGAR
May 27, 2026 - Brett Hale view on EDGAR
May 27, 2026 - Thomas Teisseyre view on EDGAR
May 22, 2026 - Ruth A. Fattori view on EDGAR
May 22, 2026 - Dan Wolterman view on EDGAR
May 22, 2026 - John T. Dahldorf view on EDGAR
May 22, 2026 - Jonathan M. Rothberg view on EDGAR

Related companies with recent insider activity

Learn more

Insider selling: signal or noise?: Why most insider sales are routine, and the few patterns worth a second look.
Insider activity in Health Care: Where HYPR's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow HYPR with a 7-day demo

HYPR on your watchlist
Every HYPR Form 4 filing on record
Up to 3 months of HYPR price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Open-market sale

14,690

$13K

Date

Insider

Transaction

Security

Price

Value

Aug 24, 2026

Thomas Teisseyre - Officer

Open-market sale

Class A Common Stock

7,345^{footnote F1}

$0.85^{footnote F2}

$6K

Footnote F1 (shares): The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 31, 2025 pursuant to a "sell to cover" provision included in the RSU Agreement.
Footnote F2 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $0.854 to $0.868 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR

Aug 24, 2026

Brett Hale - Officer

Open-market sale

Class A Common Stock

7,345^{footnote F1}

$0.85^{footnote F2}

$6K

Footnote F1 (shares): The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 31, 2025 pursuant to a "sell to cover" provision included in the RSU agreement.
Footnote F2 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $0.854 to $0.868 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange… Full note on SEC EDGAR

Jun 3, 2026

Dan Wolterman

Grant or award

Stock Options (right to buy)

52,600

$0.00

May 26, 2026

Brett Hale - Officer

Open-market sale

Class A Common Stock

6,047^{footnote F1}

$1.65^{footnote F2}

$10K

Footnote F1 (shares): The sales reported in ths Form 4 were effected to cover tax witholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 31, 2025 pursuant to a "sell to over" provision included in the RSU agreement.
Footnote F2 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $1.63 to $1.715 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission… Full note on SEC EDGAR

May 26, 2026

Thomas Teisseyre - Officer

Open-market sale

Class A Common Stock

6,047^{footnote F1}

$1.65^{footnote F2}

$10K

Footnote F1 (shares): The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 31, 2025 pursuant to a "sell to cover" provision included in the RSU Agreement.
Footnote F2 (price): Represents the weighted average sales price per share. The shares sold at prices ranging from $1.63 to $1.715 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission… Full note on SEC EDGAR

May 22, 2026

Ruth A. Fattori

Grant or award

Stock Options (right to buy)

157,700

$0.00

May 22, 2026

Dan Wolterman

Grant or award

Stock Options (right to buy)

157,700

$0.00

May 22, 2026

John T. Dahldorf

Grant or award

Stock Options (right to buy)

157,700

$0.00

May 22, 2026

Jonathan M. Rothberg

Grant or award

Stock Options (right to buy)

157,700

$0.00

Mar 31, 2026

Brett Hale - Officer

Grant or award

Class A Common Stock

330,000^{footnote F1}

$0.00

Footnote F1 (shares): Consist of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest 25% on March 23, 2027, with the remainder vesting in equal quarterly installments over the following three years, subject to Mr… Full note on SEC EDGAR

Mar 31, 2026

Thomas Teisseyre - Officer

Grant or award

Class A Common Stock

330,000^{footnote F1}

$0.00

Footnote F1 (shares): Consist of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest 25% on March 23, 2027, with the remainder vesting in equal quarterly installments over the following three years, subject to Dr… Full note on SEC EDGAR

Mar 31, 2026

Maria Sainz - Officer

Grant or award

Class A Common Stock

750,000^{footnote F1}

$0.00

Footnote F1 (shares): Consist of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest 25% on March 23, 2027, with the remainder vesting in equal quarterly installments over the following three years, subject to Ms… Full note on SEC EDGAR

Mar 23, 2026

Thomas Teisseyre - Officer

Open-market sale

Class A Common Stock

24,188

$1.21^{footnote F1}

$29K

Footnote F1 (price): The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 31, 2025 pursuant to a "sell to cover" provision included in the RSU Agreement.

Mar 23, 2026

Brett Hale - Officer

Open-market sale

Class A Common Stock

24,188^{footnote F1}

$1.21

$29K

Footnote F1 (shares): The sales reported in ths Form 4 were effected to cover tax witholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 31, 2025 pursuant to a "sell to over" provision included in the RSU agreement.

Feb 13, 2026

Thomas Teisseyre - Officer

Open-market sale

Class A Common Stock

821

$1.11^{footnote F1}

$913

Footnote F1 (price): The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 28, 2022 and April 28, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

Nov 19, 2025

Thomas Teisseyre - Officer

Open-market sale

Class A Common Stock

1,405

$1.08^{footnote F1}

$2K

Footnote F1 (price): The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted on March 28, 2022 and April 28, 2022 pursuant to a "sell to cover" provision included in the RSU Agreement.

Aug 18, 2025

Thomas Teisseyre - Officer

Open-market sale

Class A Common Stock

1,151

$1.33

$2K

May 20, 2025

Ruth A. Fattori

Grant or award

Stock Options (right to buy)

79,200

$0.00

Nov 18, 2024

Thomas Teisseyre - Officer

Open-market sale

Class A Common Stock

2,800

$0.85

$2K